Catalog #XA11
Semax
10 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$40.00
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). It demonstrates nootropic and neuroprotective properties through BDNF upregulation, modulation of dopaminergic and serotonergic systems, and enhancement of neuronal plasticity.
Simplified Explanation
Semax is a synthetic peptide based on a fragment of ACTH hormone. In laboratory studies, it has been shown to upregulate BDNF and modulate neurotransmitter systems. Researchers study its effects on neuronal signaling pathways and gene expression in neural tissue models.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Certificate of Analysis (COA)
THIRD-PARTY VERIFIEDIndependent third-party HPLC and mass spectrometry analysis is provided for every batch.
Customer Reviews
No reviews yet — be the first to share your experience.
Related Research Peptides
From Our Research Blog
Background reading and laboratory context for Semax 10 MG — sourced from our research articles.
research
Pinealon: What a tripeptide suggests about cognition
Pinealon (PI20) is a short peptide studied for neurobiology and cognition. Here's what preclinical literature suggests, plus pract…
Aug 2, 2026
research
Semax neurotrophic research: BDNF, stress, focus
A research-first tour of Semax: proposed neurotrophic signaling, stress-axis effects, and how labs frame its mechanisms without hy…
Jul 28, 2026
research
BPC-157 mechanism of action: current research
A research-first look at BPC-157: proposed signaling pathways, preclinical findings, key uncertainties, and what labs are studying…
Jul 15, 2026
research
Other Trending Peptides in the Spotlight: What's Next?
A research-first tour of trending peptides-cagrilintide, semax, and others-covering mechanisms, preclinical signals, and lab quest…
Jul 13, 2026
research
Selank in cognitive research: calm focus, mechanistically
Selank is a neuroactive research peptide studied for stress-linked cognition. Here's what preclinical literature suggests about it…
Jul 12, 2026
research
CagriSema: what the combo teaches metabolic research
CagriSema pairs an amylin-pathway agonist with a GLP-1 agonist. Here's what preclinical and early studies suggest-and what remains…
Jul 7, 2026
